A2A Pharma
ceuticals develops novel drugs for treating antibiotic-resistant bacterial infections, tuberculosis and cancer... Read moreA2A Pharma
ceuticals develops novel drugs for treating antibiotic-resistant bacterial infections, tuberculosis and cancer... Read more
News
Dec 17, 2024
StreetInsider
Press Release: A2A Pharma : /C O R R E C T I O N -- A2A Pharmaceuticals, Inc./
Dec 11, 2024
PR Newswire
Press Release: A2A Pharma : A2A Pharmaceuticals, Inc. Announces Phase 1 Clinical Trial Advancements in TACC3 Inhibition Program Targeting Multiple Cancers
May 19, 2022
Area Development Online
A2A Pharma: A2A Pharmaceutical Network Plans Scottsville, Kentucky, Headquarters
Jun 09, 2020
Contract Pharma
A2A Pharma: A2A Pharmaceuticals Collaborates with Laxai Life Sciences
Jun 08, 2020
FIRSTWORD PHARMA
A2A Pharma: A2A Pharmaceuticals Collaborates With LAXAI Life Sciences to Co-develop SARS-CoV-2 Main Proteases Inhibitors for the Treatment of COVID-19
Jan 14, 2020
Medical Buyer
A2A Pharma: A2A Pharma Agreement With Daewoong Pharma For AI-Enhanced Oncology
Sep 30, 2019
BioPortfolio
A2A Pharma: A2A Pharmaceuticals Appoints New Advisors
Sep 30, 2019
firstwordpharma
A2A Pharma: A2A Pharmaceuticals Appoints New Advisors
Jul 23, 2018
BioPortfolio
A2A Pharmaceuticals: Two Artificial Intelligence Companies Partner to Take on DMD and Orphan Diseases
Jul 20, 2018
FierceBiotechIT
A2A Pharmaceuticals: Insilico and A2A launch new Duchenne-focused AI drug company